Alnylam Pharmaceuticals Aktie
275,50
EUR
+1,00
EUR
+0,36
%
315,95
USD
-1,42
USD
-0,45
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung